President-elect Donald Trump has encouraged him to “go wild on health” but has not made clear what role Mr. Kennedy will play.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2024-11-06 22:56:352024-11-06 22:56:35Robert F. Kennedy Jr., Foe of Drug Makers and Regulators, Is Poised to Wield New Power
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.